TRxADE HEALTH, Inc. (MEDS)

Market Cap	4.01M
Revenue (ttm)	11.31M
Net Income (ttm)	-3.33M
Shares Out	9.32M
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	21.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	686,214
Open	0.370
Previous Close	0.374
Day's Range	0.370 - 0.449
52-Week Range	0.271 - 3.470
Beta	1.06
Analysts	Buy
Price Target	2.30 (+434.88%)
Earnings Date	May 8, 2023

About MEDS

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TR...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• IPO Date: Feb 13, 2020
• Employees: 47
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDS

Financial Performance

In 2021, TRxADE HEALTH's revenue was $9.89 million, a decrease of -42.24% compared to the previous year's $17.12 million. Losses were -$5.32 million, 109.6% more than in 2020.

Analyst Forecast

According to 9 analysts, the average rating for MEDS stock is "Buy." The 12-month stock price forecast is $2.3, which is an increase of 434.88% from the latest price.

Price Target

$2.3

(434.88% upside)

Analyst Consensus: Buy